The heart transplant market size is projected to reach US$ 35,470.84 million by 2030 from US$ 15,472.79 million in 2022. The market is expected to register a CAGR of 10.9% during 2022–2030. Growing adoption of AI in heart transplantation procedures for detection of early signs and seriousness of the host rejection post-heart transplantation are likely to remain key trends in the market.
The number of geriatric population and patients suffering from cardiovascular diseases is increasing, which are the key market drivers for market growth. The demand for cardiac surgeries and treatments is also increasing as more and more people are getting prone to cardiovascular diseases across the world, which is also driving up the heart transplant market growth. The demand for heart transplants is further increasing because of the aging population and large number of individuals diagnosed with high blood cholesterol levels. Furthermore, the increasing mortality rate due to heart failure is also a factor bolstering the market growth. Both the cases of heart failure and coronary heart disease have increased significantly in the last decade. These cardiovascular diseases often require heart transplants, so this is one of the crucial elements driving the growth of the heart transplant market.
Companies operating in the heart transplant market are focusing on collaborations, expansions, agreements, partnerships, and launching new products that help them increase their revenue, expand their geographical reach, and enhance their capacities to serve a larger than existing customer base. In 2022, a new AI system was designed known as the Cardiac Rejection Assessment Neural Estimator (CRANE), which can be used in tandem with medical assessments for rapid and precise diagnosis. In 2020, the National Institute of Health granted US$ 3.2 million for the study based on the exploration of the capabilities of AI in heart transplants. Furthermore, a few of the major contributors to the rising prevalence of CVDs leading to the market growth are ethnicity and family history. Other notable factors include increasing tobacco consumption, hypertension; and diseases such as obesity, dyslipidemia, and diabetes that are further expected to drive the market growth in near future.
According to the WHO, the aging population worldwide will grow to ~2.1 billion by 2050 from from ~1 billion in 2019. The US Census Bureau further estimates that the US population aged 65 and above would surge by 20% by the end of 2030. As per a study by Emory Healthcare, ~1.4 million people in the US over the age of 65 suffer from congestive heart failure, and more than 5% of people aged 60–69 years have this heart condition. Congestive heart failure is one of the most common diagnoses in hospitals with patients of 65 years and above age, which led to 875,000 hospitalizations in the US in 2021. Artificial heart surgeries are commonly used in managing heart failure in the geriatric population. Hence, the growing elderly population, along with the increasing prevalence of heart failure, fuels the heart transplant market growth.
Emerging countries such as India, China, Argentina, Brazil, the UAE, and South Africa are expected to offer significant growth opportunities for heart transplant market players mainly due to flourishing R&D landscape, rising patient population, growing CVD awareness, improving healthcare infrastructure, burgeoning disposable incomes, and relatively lenient policies compared to developed economies. The number of surgical centers and hospitals in developing markets would continue to grow with burgeoning healthcare spending and a rising target patient population. Therefore, the development of healthcare facilities in the developing economies, along with the rise in the number of hospitals, would in turn, result in the elevated number of heart transplantation surgeries in the coming years, creating lucrative opportunities for the heart transplant market players.
Key segments that contributed to the derivation of the Heart Transplant market analysis are surgery type, type, and end user.
The geographic scope of the heart transplant market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the heart transplant market. Factors leading to the growth of the heart transplant market in North America are an upsurge in the geriatric population, the prevalence of cardiovascular diseases, and an increase in heart failure cases. The US held the largest market share of the heart transplant market in 2022. According to data by the American Heart Association (AHA), annually ~1 million new heart failure cases are registered in the US, and it is further estimated that more than 8 million people would suffer from heart failure by 2030. In addition, the US Food and Drug Administration (FDA) is increasingly approving various heart transplant procedures and products in the country. Further, the presence of major companies also benefits the market in the US. For instance, in April 2022, TransMedics Group, Inc. received premarket FDA approval for its OCS Heart.
The regional trends and factors influencing the Heart Transplant Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Heart Transplant Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 15,472.79 Million |
| Market Size by 2030 | US$ 35,470.84 Million |
| Global CAGR (2022 - 2030) | 10.9% |
| Historical Data | 2020-2021 |
| Forecast period | 2022-2030 |
| Segments Covered |
By Surgery Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Heart Transplant Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Heart Transplant Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The heart transplant market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the heart transplant market are listed below:
The “Heart Transplant Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:
11.0% is the CAGR of the heart transplant market.
The North America region dominated the heart transplant market in 2023.
The increasing target disease incidence and growing geriatric population are the driving factors impacting the heart transplant market.
CardiacAssist Inc. and Abbott Cardiovascular are the leading players operating in the heart transplant market.
Growing adoption of AI in heart transplantation procedures are likely to act as future trends for the heart transplant market.
US$ 39.54 billion would be the estimated value of the heart transplant market by 2031.